The Hidden Costs of In-House ASC Billing for Multi-OR Surgery Centers

-
Image
Many multi-OR Ambulatory Surgery Centers (ASCs) believe that keeping billing operations in-house provides greater control and lower costs. On the surface, this approach may appear economical because salaries, software, and office expenses are easy to measure. However, the true cost of in-house ASC billing often extends far beyond payroll. As surgical volumes increase and payer requirements become more complex, hidden operational expenses can quietly erode profitability. Claim denials, delayed reimbursements, coding errors, staffing turnover, technology limitations, and compliance risks frequently cost more than administrators realize. This is why many surgery centers are reevaluating their billing strategy and comparing internal operations with specialized ASC Billing Services , comprehensive medical billing services , advanced RCM services , and proactive Revenue Integrity programs designed specifically for high-volume ASCs. Why Multi-OR ASCs Face Greater Billing Complexity A single...
Post a Comment

Medicare Coverage for Vagus Nerve Stimulation (VNS)

-

 

medicarecoverageforvagusnervestimulationvns.jpg

Vagus Nerve Stimulation (VNS) is a pulse generator, similar to a pacemaker, that is surgically implanted under the skin of the left chest and an electrical lead (wire) is connected from the generator to the left vagus nerve. Electrical signals are sent from the battery-powered generator to the vagus nerve via the lead. These signals are in turn sent to the brain. VNS provides indirect modulation of brain activity through the stimulation of the vagus nerve. The vagus nerve, the tenth cranial nerve, has parasympathetic outflow that regulates the autonomic (involuntary) functions of heart rate and gastric acid secretion and also includes the primary functions of sensation from the pharynx, muscles of the vocal cords, and swallowing. It is a nerve that carries both sensory and motor information to/from the brain. Medicare coverage for many tests, items, and services depends on where you live. 

Nationally Covered Indications 

VNS treatment is reasonable and necessary for patients with medically refractory partial-onset seizures for whom surgery is not recommended or for whom surgery has failed. Effective for services performed on or after February 15, 2019, the Centers for Medicare & Medicaid Services (CMS) will cover FDA-approved vagus nerve stimulation (VNS) devices for treatment-resistant depression (TRD) through Coverage with Evidence Development (CED) when offered in a CMS-approved, double-blind, randomized, placebo-controlled trial with a follow-up duration of at least one year with the possibility of extending the study to a prospective longitudinal study when the CMS-approved, double-blind, randomized placebo-controlled trial has completed enrollment, and there are positive interim findings. 

Nationally Non-Covered Indications 

VNS is not reasonable and necessary for all other types of seizure disorders that are medically refractory and for whom surgery is not recommended or for whom surgery has failed. VNS is non-covered for treatment-resistant depression (TRD) when furnished outside of a CMS-approved Coverage with Evidence Development (CED) study. All other indications of VNS for the treatment of depression are nationally non-covered. 

Patient Criteria

The following criteria must be used to identify patients demonstrating treatment-resistant depression (TRD):

  • The patient must be in a major depressive disorder (MDD) episode for ≥ two years or have had at least four episodes of MDD, including the current episode. In order to confirm the patient has MDD, accepted diagnostic criteria from the most current edition of the Diagnostic and Statistical Manual for Mental Disorder (DSM) and a structured clinical assessment are to be used. 
  • The patient’s depressive illness meets a minimum criterion of four prior failed treatments of adequate dose and duration as measured by a tool designed for this purpose. 
  • The patient is experiencing a major depressive episode (MDE) as measured by a guideline-recommended depression scale assessment tool on two visits, within a 45-day span before implantation of the VNS device.
  • Patients must maintain a stable medication regimen for at least four weeks before device implantation. 
  • If patients with bipolar disorder are included, the condition must be carefully characterized.

To learn more about Medicare Coverage for Vagus Nerve Stimulation, click here: https://bit.ly/3RQfMiJ, Contact us at info@medicalbillersandcoders.com/ 888-357-3226.

Location: United States

Comments

Post a Comment

Popular posts from this blog

Is Your Neurology Billing Outsourcing Helping or Hurting You at Year-End?

-
Image
  As year-end approaches, neurology practices face a crucial decision: Is your billing outsourcing truly improving your financial performance, or silently affecting your revenue? Neurology billing is complex due to time-based coding, modifier usage, high documentation requirements, frequent audits, and prior authorization challenges. If your billing partner lacks neurology-specific expertise, it may lead to claim denials, revenue loss, and compliance risks. Signs Your Neurology Billing Outsourcing Is Helping If your billing partner is performing well, you will see: • Reduced denial rates for neurology codes (EEG, EMG, Botox, Nerve Conduction Studies) • Faster reimbursements and fewer delays from payers • Active recovery of old AR beyond 60, 90, or 120+ days • Accurate CPT, ICD-10, and modifier usage for neurology procedures • Clear billing reports, denial analysis, and revenue insights • Compliance with Medicare, commercial payers, and documentation standards Warning ...
Read more

How Hidden OB-GYN Billing Errors Are Quietly Costing You Millions Each Year

-
Image
  The Silent Revenue Leak in OB-GYN Practices Most OB-GYN practices don’t realize they’re bleeding money. Not in dramatic, headline-grabbing ways, but quietly, steadily, month after month. The phones are ringing, appointment slots are full, deliveries are happening, and yet the numbers never seem to match the effort. Sound familiar? This is often the first sign of hidden OB-GYN billing errors working behind the scenes. These errors don’t announce themselves. They don’t crash your systems or send angry alerts. Instead, they slip through claims, hide in coding nuances, and quietly shave thousands—or millions—off your annual revenue. OB-GYN billing is uniquely complex compared to other specialties. Between global maternity packages, split billing scenarios, high-risk pregnancy coding, and ever-changing payer rules, the margin for error is enormous. A single missed modifier or incorrectly bundled service might seem insignificant on its own. But when repeated across hundreds or thousand...
Read more

The #1 Reason ASCs Lose Revenue from Medicare Claims (And How to Fix It)

-
Image
Ambulatory Surgical Centers don’t lose Medicare revenue because of low case volume. They lose it because of one recurring, preventable failure: Incorrect coding and documentation for Medicare’s ASC-specific payment rules. This single issue triggers denials, underpayments, delayed reimbursement, and permanent write-offs — especially at year-end. If your ASC’s Medicare revenue feels unpredictable, this is why. The #1 Revenue Killer: Not Billing Medicare the “ASC Way” Medicare does not treat ASCs like hospitals or physician offices. Yet many ASCs still: Use hospital-style assumptions Miss ASC-only payment rules Underestimate Medicare’s bundling logic The result? Claims get paid less than expected — or not at all. Where Medicare ASC Claims Go Wrong 1. Incorrect CPT eligibility for ASC payment Not every CPT code is payable in an ASC setting under Medicare. Common mistakes: Billing procedures not on Medicare’s ASC approved list Assuming “covered in hospital” = “covered in ASC” Missing annual...
Read more